K.J. Harrison & Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Sell
20,596
-55,000
-73% -$4.85M 0.24% 107
2026
Q2
$5.91M Buy
75,596
+62,000
+456% +$5M 0.84% 31
2026
Q1
$1.18M Buy
+13,596
New +$1.3M 0.19% 116
2025
Q4
– Sell
-16,620
Closed -$1.59M – 240
2025
Q3
$1.59M Buy
+16,620
New +$1.53M 0.23% 108
2024
Q1
– Sell
-4,800
Closed -$395K – 214
2023
Q4
$395K Buy
+4,800
New +$366K 0.07% 172
2023
Q3
– Sell
-12,300
Closed -$1.08M – 171
2023
Q2
$1.08M Buy
+12,300
New +$1.06M 0.2% 120
2023
Q1
– Sell
-2,000
Closed -$211K – 261
2022
Q4
$211K Buy
+2,000
New +$162K 0.04% 194
2022
Q1
– Sell
-4,100
Closed -$425K – 357
2021
Q4
$425K Buy
+4,100
New +$475K 0.06% 206
2020
Q4
– Sell
-6,000
Closed -$624K – 299
2020
Q3
$624K Buy
+6,000
New +$603K 0.13% 153

Other funds holding MDT

K.J. Harrison & Partners's MDT Position: Q3 2026 in Review

K.J. Harrison & Partners reduced its Medtronic (MDT) stake by 73% in Q3 2026, selling an estimated $4.85M and leaving 20,596 shares worth $1.78M. The position accounts for 0.24% of the portfolio, ranked #107.

K.J. Harrison & Partners first reported a position in MDT in Q3 2020 and has held it in 9 quarters since. The position peaked at $5.91M in Q2 2026. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • K.J. Harrison & Partners held 20,596 shares of Medtronic worth $1.78M as of Q3 2026.
  • K.J. Harrison & Partners sold 55,000 Medtronic shares in Q3 2026, an estimated $4.85M.
  • Medtronic made up 0.24% of K.J. Harrison & Partners's portfolio in Q3 2026, its #107 holding.
  • K.J. Harrison & Partners first reported a position in Medtronic in Q3 2020 and has held it in 9 quarters since.
  • K.J. Harrison & Partners's Medtronic position peaked at $5.91M in Q2 2026.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on K.J. Harrison & Partners's 13F filing for Q3 2026, filed 12 Nov 2026.